{"transactions":[{"id":701798,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-07-30T00:05:03.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":2224342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continued employment."}],"balance_after":2224342,"derivative":{"exercise_price":17.74,"exercise_date":"2027-07-28","expiration_date":"2036-07-28","underlying":"Common Stock","underlying_shares":2224342},"source":{"system":"sec-edgar","filing":"0001193125-26-324445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526324445/ownership.xml","form_type":"4"}},{"id":701797,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-30T00:05:03.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":756104,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in substantially equal installments on an annual basis over four years from the date of grant, subject to the Reporting Person's continued employment."}],"balance_after":756104,"source":{"system":"sec-edgar","filing":"0001193125-26-324445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526324445/ownership.xml","form_type":"4"}},{"id":784344,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-11T20:38:33.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":25270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 07, 2027."}],"balance_after":85821,"source":{"system":"sec-edgar","filing":"0001628280-26-033598","document":"wk-form4_1778531911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000162828026033598/wk-form4_1778531911.xml","form_type":"4"}},{"id":850281,"issuer":{"id":3277,"kind":"organization","name":"Viatris Inc","symbol":"VTRS"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-03-10T23:03:58.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":15890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027."}],"balance_after":15890,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":15890},"source":{"system":"sec-edgar","filing":"0001140361-26-008883","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000114036126008883/form4.xml","form_type":"4"}},{"id":850280,"issuer":{"id":3277,"kind":"organization","name":"Viatris Inc","symbol":"VTRS"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true}}],"security":"Dividend Equivalent Units","published_at":"2026-03-10T23:03:58.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":918.455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on May 12, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on May 12, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":918.455},"source":{"system":"sec-edgar","filing":"0001140361-26-008883","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000114036126008883/form4.xml","form_type":"4"}},{"id":850279,"issuer":{"id":3277,"kind":"organization","name":"Viatris Inc","symbol":"VTRS"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-03-10T23:03:58.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":25112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":25112},"source":{"system":"sec-edgar","filing":"0001140361-26-008883","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000114036126008883/form4.xml","form_type":"4"}},{"id":850278,"issuer":{"id":3277,"kind":"organization","name":"Viatris Inc","symbol":"VTRS"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-10T23:03:58.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan."}],"balance_after":26031,"source":{"system":"sec-edgar","filing":"0001140361-26-008883","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000114036126008883/form4.xml","form_type":"4"}},{"id":850277,"issuer":{"id":3277,"kind":"organization","name":"Viatris Inc","symbol":"VTRS"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-10T23:03:58.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":25112,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25112,"source":{"system":"sec-edgar","filing":"0001140361-26-008883","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000114036126008883/form4.xml","form_type":"4"}},{"id":1150400,"issuer":{"id":3277,"kind":"organization","name":"Viatris Inc","symbol":"VTRS"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-13T22:04:29.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":25112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2026."}],"balance_after":25112,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":25112},"source":{"system":"sec-edgar","filing":"0001140361-25-018715","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000114036125018715/form4.xml","form_type":"4"}},{"id":1151953,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T21:33:08.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":17100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 08, 2026."}],"balance_after":60551,"source":{"system":"sec-edgar","filing":"0001722482-25-000145","document":"wk-form4_1747085579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000172248225000145/wk-form4_1747085579.xml","form_type":"4"}},{"id":1518769,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T20:28:37.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":8477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 09, 2025."}],"balance_after":43451,"source":{"system":"sec-edgar","filing":"0001722482-24-000113","document":"wk-form4_1715632104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000172248224000113/wk-form4_1715632104.xml","form_type":"4"}},{"id":1893045,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T20:47:13.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":9808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 11, 2024."}],"balance_after":34974,"source":{"system":"sec-edgar","filing":"0001722482-23-000121","document":"wf-form4_168418361451845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000172248223000121/wf-form4_168418361451845.xml","form_type":"4"}},{"id":65815,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-25T20:58:03.000Z","date":"2022-05-23","kind":"exercise","acquired":false,"shares":21739,"price":105.92,"value":2302594.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":43478,"derivative":{"exercise_price":105.92,"exercise_date":"2022-02-18","expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":21739},"source":{"system":"sec-edgar","filing":"0001179110-22-003137","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/edgar.xml","form_type":"4"}},{"id":65814,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-25T20:58:03.000Z","date":"2022-05-23","kind":"exercise","acquired":false,"shares":11742,"price":93.5,"value":1097877.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":38188,"derivative":{"exercise_price":93.5,"exercise_date":"2021-02-20","expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":11742},"source":{"system":"sec-edgar","filing":"0001179110-22-003137","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/edgar.xml","form_type":"4"}},{"id":65813,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-25T20:58:03.000Z","date":"2022-05-23","kind":"exercise","acquired":false,"shares":46320,"price":114.36,"value":5297155.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":114.36,"exercise_date":"2019-02-15","expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":46320},"source":{"system":"sec-edgar","filing":"0001179110-22-003137","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/edgar.xml","form_type":"4"}},{"id":65812,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-25T20:58:03.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":11605,"price":151.53,"value":1758505.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.13 to $151.58 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":152103,"source":{"system":"sec-edgar","filing":"0001179110-22-003137","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/edgar.xml","form_type":"4"}},{"id":65811,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-25T20:58:03.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":68196,"price":150.79,"value":10283274.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.13 to $151.12 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":163708,"source":{"system":"sec-edgar","filing":"0001179110-22-003137","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/edgar.xml","form_type":"4"}},{"id":65810,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-25T20:58:03.000Z","date":"2022-05-23","kind":"exercise","acquired":true,"shares":21739,"price":105.92,"value":2302594.88,"ownership":{"direct":true},"balance_after":231904,"source":{"system":"sec-edgar","filing":"0001179110-22-003137","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/edgar.xml","form_type":"4"}},{"id":65809,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-25T20:58:03.000Z","date":"2022-05-23","kind":"exercise","acquired":true,"shares":11742,"price":93.5,"value":1097877.0,"ownership":{"direct":true},"balance_after":210165,"source":{"system":"sec-edgar","filing":"0001179110-22-003137","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/edgar.xml","form_type":"4"}},{"id":65808,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-25T20:58:03.000Z","date":"2022-05-23","kind":"exercise","acquired":true,"shares":46320,"price":114.36,"value":5297155.2,"ownership":{"direct":true},"balance_after":198423,"source":{"system":"sec-edgar","filing":"0001179110-22-003137","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/edgar.xml","form_type":"4"}},{"id":66092,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-17","kind":"exercise","acquired":false,"shares":64636,"price":93.5,"value":6043466.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":49930,"derivative":{"exercise_price":93.5,"exercise_date":"2021-02-20","expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":64636},"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66091,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-17","kind":"exercise","acquired":false,"shares":35364,"price":79.02,"value":2794463.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":79.02,"exercise_date":"2020-02-21","expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":35364},"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66090,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-16","kind":"exercise","acquired":false,"shares":29121,"price":79.2,"value":2306383.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":35364,"derivative":{"exercise_price":79.02,"exercise_date":"2020-02-21","expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":29121},"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66089,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-16","kind":"exercise","acquired":false,"shares":70879,"price":61.36,"value":4349135.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":61.36,"exercise_date":"2018-02-16","expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":70879},"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66088,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-17","kind":"sale","acquired":false,"shares":2100,"price":155.27,"value":326067.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at a price of $155.27. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":152103,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66087,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-17","kind":"sale","acquired":false,"shares":54279,"price":154.49,"value":8385562.71,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.02 to $155.00 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":154203,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66086,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-17","kind":"sale","acquired":false,"shares":43621,"price":153.43,"value":6692770.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.95 to $153.92 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":208482,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66085,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-17","kind":"exercise","acquired":true,"shares":64636,"price":93.5,"value":6043466.0,"ownership":{"direct":true},"balance_after":252103,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66084,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-17","kind":"exercise","acquired":true,"shares":35364,"price":79.02,"value":2794463.28,"ownership":{"direct":true},"balance_after":187467,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66083,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":400,"price":155.44,"value":62176.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at a price of $155.44. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":152103,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66082,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":53327,"price":154.8,"value":8255019.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.38 to $154.81 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":152503,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66081,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":46273,"price":154.04,"value":7127892.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.38 to $154.37 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":205830,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66080,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-16","kind":"exercise","acquired":true,"shares":29121,"price":79.02,"value":2301141.42,"ownership":{"direct":true},"balance_after":252103,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":66079,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-18T21:12:28.000Z","date":"2022-05-16","kind":"exercise","acquired":true,"shares":70879,"price":61.36,"value":4349135.44,"ownership":{"direct":true},"balance_after":222982,"source":{"system":"sec-edgar","filing":"0001179110-22-003077","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/edgar.xml","form_type":"4"}},{"id":2269774,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T22:17:19.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":6693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 12, 2023."}],"balance_after":25166,"source":{"system":"sec-edgar","filing":"0001722482-22-000131","document":"wf-form4_165273941969121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000172248222000131/wf-form4_165273941969121.xml","form_type":"4"}},{"id":66457,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-10","kind":"exercise","acquired":false,"shares":29221,"price":61.36,"value":1793000.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":70879,"derivative":{"exercise_price":61.36,"exercise_date":"2018-02-16","expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":29221},"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66456,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-10","kind":"exercise","acquired":false,"shares":70779,"price":58.88,"value":4167467.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":58.88,"exercise_date":"2016-02-19","expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":70779},"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66455,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":33701,"price":58.88,"value":1984314.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":70779,"derivative":{"exercise_price":58.88,"exercise_date":"2016-02-19","expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":33701},"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66454,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":66299,"price":54.86,"value":3637163.14,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":54.86,"exercise_date":"2017-02-18","expiration_date":"2026-02-17","underlying":"Common Stock","underlying_shares":66299},"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66453,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-06","kind":"exercise","acquired":false,"shares":25691,"price":54.86,"value":1409408.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":66299,"derivative":{"exercise_price":54.86,"exercise_date":"2017-02-18","expiration_date":"2026-02-17","underlying":"Common Stock","underlying_shares":25691},"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66452,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-06","kind":"exercise","acquired":false,"shares":74309,"price":54.44,"value":4045381.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":54.44,"exercise_date":"2015-06-02","expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":74309},"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66451,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":48591,"price":152.83,"value":7426162.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.55 to $153.50 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":152103,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66450,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":28536,"price":152.24,"value":4344320.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.55 to $152.54 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":200694,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66449,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":22873,"price":151.16,"value":3457482.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.55 to $151.54 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":229230,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66448,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-10","kind":"exercise","acquired":true,"shares":29221,"price":61.36,"value":1793000.56,"ownership":{"direct":true},"balance_after":252103,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66447,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-10","kind":"exercise","acquired":true,"shares":70779,"price":58.88,"value":4167467.52,"ownership":{"direct":true},"balance_after":222882,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66446,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":21071,"price":151.42,"value":3190570.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.04 to $151.93 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":152103,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66445,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":31714,"price":150.63,"value":4777079.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.04 to $151.03 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":173174,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66444,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":47215,"price":149.53,"value":7060058.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.04 to $150.03 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":204888,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66443,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":33701,"price":58.88,"value":1984314.88,"ownership":{"direct":true},"balance_after":252103,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66442,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":66299,"price":54.86,"value":3637163.14,"ownership":{"direct":true},"balance_after":218402,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66441,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-06","kind":"sale","acquired":false,"shares":13836,"price":151.78,"value":2100028.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.58 to $151.95 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":152103,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66440,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-06","kind":"sale","acquired":false,"shares":45988,"price":151.13,"value":6950166.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.58 to $151.57 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":165939,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66439,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-06","kind":"sale","acquired":false,"shares":40176,"price":150.1,"value":6030417.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.58 to $150.57 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":211927,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66438,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-06","kind":"exercise","acquired":true,"shares":25691,"price":54.86,"value":1409408.26,"ownership":{"direct":true},"balance_after":252103,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":66437,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-10T21:05:03.000Z","date":"2022-05-06","kind":"exercise","acquired":true,"shares":74309,"price":54.44,"value":4045381.96,"ownership":{"direct":true},"balance_after":226412,"source":{"system":"sec-edgar","filing":"0001179110-22-002947","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/edgar.xml","form_type":"4"}},{"id":2303467,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T20:57:17.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":1215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 11, 2022."}],"balance_after":18473,"source":{"system":"sec-edgar","filing":"0001722482-22-000081","document":"wf-form4_164919221986621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000172248222000081/wf-form4_164919221986621.xml","form_type":"4"}},{"id":69868,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:08:11.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":38857,"price":149.54,"value":5810675.78,"ownership":{"direct":true},"balance_after":152103,"source":{"system":"sec-edgar","filing":"0001179110-22-001829","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001829/edgar.xml","form_type":"4"}},{"id":70265,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (Right to Buy)","published_at":"2022-02-22T22:32:41.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":48161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,054 on February 17, 2023, 16,054 on February 17, 2024, and 16,053 on February 17, 2025."}],"balance_after":48161,"derivative":{"exercise_price":144.54,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":48161},"source":{"system":"sec-edgar","filing":"0001179110-22-001507","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001507/edgar.xml","form_type":"4"}},{"id":70264,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:32:41.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":11565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":190960,"source":{"system":"sec-edgar","filing":"0001179110-22-001507","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001507/edgar.xml","form_type":"4"}},{"id":70263,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:32:41.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":17468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":179395,"source":{"system":"sec-edgar","filing":"0001179110-22-001507","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001507/edgar.xml","form_type":"4"}},{"id":70262,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:32:41.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":10477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":161927,"source":{"system":"sec-edgar","filing":"0001179110-22-001507","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001507/edgar.xml","form_type":"4"}},{"id":70261,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:32:41.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":48198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":151450,"source":{"system":"sec-edgar","filing":"0001179110-22-001507","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001507/edgar.xml","form_type":"4"}},{"id":73701,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-12-30T22:01:25.000Z","date":"2021-12-27","kind":"gift","acquired":false,"shares":583,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":103252,"source":{"system":"sec-edgar","filing":"0001179110-21-011274","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021011274/edgar.xml","form_type":"4"}},{"id":92099,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-03-03T01:26:32.000Z","date":"2021-02-28","kind":"tax_withholding","acquired":false,"shares":29077,"price":107.74,"value":3132755.98,"ownership":{"direct":true},"balance_after":103835,"source":{"system":"sec-edgar","filing":"0001179110-21-002592","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002592/edgar.xml","form_type":"4"}},{"id":2825294,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-01T22:34:50.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":7236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on February 25, 2022."}],"balance_after":17258,"source":{"system":"sec-edgar","filing":"0001722482-21-000093","document":"wf-form4_161463806896980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000172248221000093/wf-form4_161463806896980.xml","form_type":"4"}},{"id":92751,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option(right to buy)","published_at":"2021-02-22T23:23:04.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":65217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 21,739 on February 18, 2022 21,739 on February 18, 2023, and 21,739 on February 18, 2024."}],"balance_after":65217,"derivative":{"exercise_price":105.92,"exercise_date":"2022-02-18","expiration_date":"2031-02-17","underlying":"Common stock","underlying_shares":65217},"source":{"system":"sec-edgar","filing":"0001179110-21-002049","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002049/edgar.xml","form_type":"4"}},{"id":92750,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:23:04.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":17468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":132912,"source":{"system":"sec-edgar","filing":"0001179110-21-002049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002049/edgar.xml","form_type":"4"}},{"id":92749,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:23:04.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":10477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":115444,"source":{"system":"sec-edgar","filing":"0001179110-21-002049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002049/edgar.xml","form_type":"4"}},{"id":92748,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:23:04.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":8565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":104967,"source":{"system":"sec-edgar","filing":"0001179110-21-002049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002049/edgar.xml","form_type":"4"}},{"id":92747,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:23:04.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":29121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":". Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":96402,"source":{"system":"sec-edgar","filing":"0001179110-21-002049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002049/edgar.xml","form_type":"4"}},{"id":99098,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-11-06T21:29:36.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":90679,"price":93.61,"value":8488461.19,"ownership":{"direct":true},"balance_after":67281,"source":{"system":"sec-edgar","filing":"0001179110-20-010868","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020010868/edgar.xml","form_type":"4"}},{"id":3169937,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:54:04.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":10022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on April 23, 2021."}],"balance_after":10022,"source":{"system":"sec-edgar","filing":"0001722482-20-000078","document":"wf-form4_158776162686571.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609447/000172248220000078/wf-form4_158776162686571.xml","form_type":"4"}},{"id":106568,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-03-03T21:57:09.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":33492,"price":85.42,"value":2860886.64,"ownership":{"direct":true},"balance_after":157960,"source":{"system":"sec-edgar","filing":"0001179110-20-002865","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002865/edgar.xml","form_type":"4"}},{"id":107175,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (right to buy)","published_at":"2020-02-24T23:00:05.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":114566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,189 on February 20, 2021, 38,189 on February 20, 2022, and 38,188 on February 20, 2023."}],"balance_after":114566,"derivative":{"exercise_price":93.5,"exercise_date":"2021-02-20","expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":114566},"source":{"system":"sec-edgar","filing":"0001179110-20-002129","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002129/edgar.xml","form_type":"4"}},{"id":107174,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:00:05.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":10479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":191452,"source":{"system":"sec-edgar","filing":"0001179110-20-002129","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002129/edgar.xml","form_type":"4"}},{"id":107173,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:00:05.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":8565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":180973,"source":{"system":"sec-edgar","filing":"0001179110-20-002129","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002129/edgar.xml","form_type":"4"}},{"id":107172,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:00:05.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":14989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":172408,"source":{"system":"sec-edgar","filing":"0001179110-20-002129","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002129/edgar.xml","form_type":"4"}},{"id":107171,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T23:00:05.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":41562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":157419,"source":{"system":"sec-edgar","filing":"0001179110-20-002129","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002129/edgar.xml","form_type":"4"}},{"id":118965,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common stock, $0.01 par value","published_at":"2019-03-04T21:59:23.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":26710,"price":79.41,"value":2121041.1,"ownership":{"direct":true},"balance_after":115857,"source":{"system":"sec-edgar","filing":"0001179110-19-003095","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019003095/edgar.xml","form_type":"4"}},{"id":119475,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Option (right to buy)","published_at":"2019-02-22T22:20:29.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":64485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 21,495 on February 21, 2020, 21,495 on February 21, 2021, and 21,495 on February 21, 2022."}],"balance_after":64485,"derivative":{"exercise_price":79.02,"exercise_date":"2020-02-21","expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":64485},"source":{"system":"sec-edgar","filing":"0001179110-19-002370","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002370/edgar.xml","form_type":"4"}},{"id":119474,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:20:29.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":8565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":142567,"source":{"system":"sec-edgar","filing":"0001179110-19-002370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002370/edgar.xml","form_type":"4"}},{"id":119473,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:20:29.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":14989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":134002,"source":{"system":"sec-edgar","filing":"0001179110-19-002370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002370/edgar.xml","form_type":"4"}},{"id":119472,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:20:29.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":15375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":119013,"source":{"system":"sec-edgar","filing":"0001179110-19-002370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002370/edgar.xml","form_type":"4"}},{"id":119471,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:20:29.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":21357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":103638,"source":{"system":"sec-edgar","filing":"0001179110-19-002370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002370/edgar.xml","form_type":"4"}},{"id":125208,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2018-08-21T20:58:04.000Z","date":"2018-08-17","kind":"sale","acquired":false,"shares":29200,"price":97.9147,"value":2859109.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.44 to $98.22, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":82281,"source":{"system":"sec-edgar","filing":"0001179110-18-010735","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018010735/edgar.xml","form_type":"4"}},{"id":125207,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common Stock, $0.01 par value","published_at":"2018-08-21T20:58:04.000Z","date":"2018-08-17","kind":"sale","acquired":false,"shares":20800,"price":96.9688,"value":2016951.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.43 to $97.43, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":111481,"source":{"system":"sec-edgar","filing":"0001179110-18-010735","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018010735/edgar.xml","form_type":"4"}},{"id":131347,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:30:15.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":2643,"price":117.928,"value":311683.704,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.91 to $117.94, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":132281,"source":{"system":"sec-edgar","filing":"0001179110-18-003337","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018003337/edgar.xml","form_type":"4"}},{"id":131346,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2018-03-02T22:30:15.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":27683,"price":118.26,"value":3273791.58,"ownership":{"direct":true},"balance_after":134924,"source":{"system":"sec-edgar","filing":"0001179110-18-003337","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018003337/edgar.xml","form_type":"4"}},{"id":132310,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Option (right to buy)","published_at":"2018-02-16T22:55:55.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":46320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 15,440 on February 15, 2019, 15,440 on February 15, 2020, and 15,440 on February 15, 2021."}],"balance_after":46320,"derivative":{"exercise_price":114.36,"exercise_date":"2019-02-15","expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":46320},"source":{"system":"sec-edgar","filing":"0001179110-18-002300","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018002300/edgar.xml","form_type":"4"}},{"id":132309,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:55:55.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":14991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":162607,"source":{"system":"sec-edgar","filing":"0001179110-18-002300","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018002300/edgar.xml","form_type":"4"}},{"id":132308,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:55:55.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":17319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":147616,"source":{"system":"sec-edgar","filing":"0001179110-18-002300","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018002300/edgar.xml","form_type":"4"}},{"id":132307,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2018-02-16T22:55:55.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":15375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2018."}],"balance_after":130297,"source":{"system":"sec-edgar","filing":"0001179110-18-002300","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018002300/edgar.xml","form_type":"4"}},{"id":135623,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2017-11-13T22:26:23.000Z","date":"2017-11-10","kind":"sale","acquired":false,"shares":25633,"price":94.6909,"value":2427211.8397,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.50 to $94.89, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":114922,"source":{"system":"sec-edgar","filing":"0001179110-17-014053","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017014053/edgar.xml","form_type":"4"}},{"id":139835,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2017-06-05T21:04:59.000Z","date":"2017-06-02","kind":"tax_withholding","acquired":false,"shares":21576,"price":66.71,"value":1439334.96,"ownership":{"direct":true},"balance_after":140555,"source":{"system":"sec-edgar","filing":"0001179110-17-008576","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017008576/edgar.xml","form_type":"4"}},{"id":142488,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2017-03-02T23:14:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":true,"shares":30699,"price":62.22,"value":1910091.78,"ownership":{"direct":true},"balance_after":162131,"source":{"system":"sec-edgar","filing":"0001179110-17-003707","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017003707/edgar.xml","form_type":"4"}},{"id":143019,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Option (right to buy)","published_at":"2017-02-21T22:53:33.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":100100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 33,367 on 02/16/2018, 33,366 on 02/16/2019, and 33,367 on 02/16/2020."}],"balance_after":100100,"derivative":{"exercise_price":61.36,"exercise_date":"2018-02-16","expiration_date":"2027-02-15","underlying":"Common stock","underlying_shares":100100},"source":{"system":"sec-edgar","filing":"0001179110-17-002816","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017002816/edgar.xml","form_type":"4"}},{"id":143018,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2017-02-21T22:53:33.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":15375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017."}],"balance_after":192830,"source":{"system":"sec-edgar","filing":"0001179110-17-002816","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017002816/edgar.xml","form_type":"4"}},{"id":143017,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2017-02-21T22:53:33.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":34173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017."}],"balance_after":177455,"source":{"system":"sec-edgar","filing":"0001179110-17-002816","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911017002816/edgar.xml","form_type":"4"}},{"id":151982,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, R&D and CSO"}}],"security":"Common stock, $0.01 par value","published_at":"2016-06-03T21:27:24.000Z","date":"2016-06-02","kind":"tax_withholding","acquired":false,"shares":21574,"price":62.83,"value":1355494.42,"ownership":{"direct":true},"balance_after":143282,"source":{"system":"sec-edgar","filing":"0001179110-16-025998","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911016025998/edgar.xml","form_type":"4"}}],"next_cursor":"2016-06-03T21:27:24.000000Z,151982"}